(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Over the years a number of excellent books have classified and detailed drug drug interactions into their respective categories, e.g. interactions at plasma protein binding sites; those altering intestinal absorption or bioavailability; those involving hepatic metabolising enzymes; those involving competition or antagonism for receptor sites, and drug interactions modifying excretory mechanisms. Such books have presented extensive tables of interactions and their management. Although of considerable value to clinicians, such publica tions have not, however, been so expressive about the individual mechanisms that underlie these interactions. It is within this sphere of "mechanisms" that this present volume specialises. It deals with mechanisms of in vitro and in vivo, drug-drug, drug food and drug-herbals interactions and those that cause drugs to interfere with diagnostic laboratory tests. We believe that an explanation of the mechanisms of such interactions will enable practitioners to understand more fully the nature of the interactions and thus enable them to manage better their clinical outcome. If mechanisms of interactions are better understood, then it may be pos sible for the researcher to develop meaningful animal/biochemical/tissue cul ture or physicochemical models to which new molecules could be exposed during their development stages. The present position, which largely relies on patients experiencing adverse interactions before they can be established or documented, can hardly be regarded as satisfactory. This present volume is classified into two major parts; firstly, pharmacoki netic drug interactions and, secondly, pharmacodynamic drug interactions.
Contents:
1 Introduction.- A. A Widening Problem.- I. Scope of This Present Volume.- B. Pharmacokinetic Drug Interactions.- I. Drug-Drug and Nutrient-Drug Interactions at the Absorption Site.- II. Drug Interactions at Plasma- and Tissue-Binding Sites.- III. Drug Interactions and Drug-Metabolising Enzymes.- IV. Interactions Involving Renal Excretory Mechanisms.- C. Pharmacodynamic Drug Interactions.- I. Drug-Drug Interactions at the Receptor and Other Active Sites.- II. Synergistic Interactions.- III. Drug Interactions In Vitro.- IV. Age and Genetic Factors.- V. Interference with Laboratory Testing.- VI. Herbal and Other Non-orthodox Medicines.- D. Comment.- I. Drug Interactions: Hazardous and Expensive Use of Resources?.- II. Sources of Information.- III. The Literature on Drug Interactions.- References.- Section I: Pharmacokinetic Drug Interactions.- 2 Drug Interactions in The Gastrointestinal Tract and Their Impact on Drug Absorption and Systemic Availability: A Mechanistic Review.- A. Introduction.- B. Physicochemical Interactions.- I. Complexation with Metal Ions.- II. Binding to Resins.- III. Complexation with Bile Salts.- IV. Nonspecific Adsorption.- C. Interactions with Drugs That Influence GI Motility and pH.- I. Alteration of Gastrointestinal Motility.- II. pH Alteration in the Gastrointestinal Tract.- D. Interactions Between Drugs That Share the Same Absorption Mechanism.- I. Passive Absorption.- II. Carrier-Mediated Absorption.- E. Interactions as a Function of Intestinal Metabolism.- F. Altered Absorption as a Result of Drug-Induced Mucosal Changes.- References.- 3 Drug-Food Interactions Affecting Drug Absorption.- A. Introduction.- I. Food.- II. Dosage Form.- B. Influence of Food on the Gastrointestinal Tract.- C. Direct Effect of Food on Drug Absorption.- D. Interactions Causing Reduced Drug Absorption.- E. Interactions Causing Delayed Drug Absorption.- F. Interactions Causing Increased Drug Absorption.- G. Interactions Causing Accelerated Drug Absorption.- H. Cases in Which Food Has No Effect on Drug Absorption.- I. Conclusions.- References.- 4 Drug Interactions at Plasma and Tissue Binding Sites.- A. Introduction.- B. Proteins Involved in Drug Binding.- C. Influence of Plasma and Tissue Binding on Drug Kinetics.- D. Displacement of Drugs from Binding Sites.- E. Therapeutic Consequences of Plasma Binding Displacement Drug-Drug Interactions.- I. Rapid Intravenous Infusion of Displacing Agent.- II. Parenteral Administration of Displaced Drug Having High Extraction Ratio.- III. Therapeutic Drug Monitoring and Drug Displacement from Plasma Binding Sites.- F. Therapeutic Consequences of Tissue Binding Displacement Interactions.- G. Displacement of Drugs from Binding Sites by Endogenous Materials.- H. Disease States and Altered Plasma Protein Binding.- I. Conclusions.- References.- 5 Drug Interactions and Drug-Metabolising Enzymes.- A. General Introduction.- B. Extrahepatic Microsomal Forms of Cytochrome P450.- C. Genetic Polymorphism.- D. Age and Disease and Cytochrome P450.- E. Clinical Importance of Enzyme Induction or Inhibition.- I. Enzyme Inducers.- II. Enzyme Inhibitors.- F. Conclusions.- References.- 6 Drug Interactions Involving Renal Excretory Mechanisms.- A. Introduction.- B. Mechanisms of Renal Excretory Clearance.- I. Anatomy and Physiology of the Kidney.- II. Glomerular Filtration.- III. Tubular Secretion.- 1. Physiological Considerations.- 2. Cellular Mechanisms.- 3. Pharmacokinetic Evidence for Tubular Secretion.- IV. Tubular Reabsorption.- C. Drug Interactions Involving Tubular Secretion.- I. Organic Anions.- 1. Probenecid.- 2. Methotrexate.- II. Organic Cations.- 1. Cimetidine.- 2. Ranitidine.- 3. Famotidine.- 4. Trimethoprim.- 5. Amiodarone.- 6. Quinine/Quinidine.- III. Organic Neutral Drugs.- 1. Digoxin.- D. Tubular Reabsorption.- I. Proximal Tubule Site.- 1. Lithium.- II. Distal Tubule/Collecting Duct Site.- 1. Urine pH and Flow Rate.- References.- Section II: Pharmacodynamic Drug Interactions.- 7 Drug-Drug Interactions at Receptors and Other Active Sites.- A. Introduction.- B. Mechanisms of Pharmacodynamic Interactions.- I. Transmitter Systems.- 1. Noradrenergic Synapse.- 2. Dopaminergic Synapse.- 3. Serotonergic Synapse.- 4. Cholinergic Synapse.- 5. GABAergic Synapse.- II. Ion Channels.- 1. Cardiac Ion Channels and Antiarrhythmic Drugs.- 2. Potassium Channels and Drug-Induced Torsades de Pointes.- 3. ATP-Sensitive Potassium Channels.- III. Hormonal Systems.- 1. Adrenal Corticosteroids.- 2. Glycaemic Regulation.- IV. Homeostatic Regulations.- 1. Renal Haemodynamics and Drug-Induced Acute Renal Failure.- 2. Prostaglandins, Natriuresis and Antihypertensive Therapy.- 3. Potassium Homeostasis.- References.- 8 Synergistic Drug Interactions.- A. Introduction: "Mithridatium".- B. Early Use of Probenecid with Penicillin.- C. Diuretic Combinations.- D. Co-trimoxazole.- E. Combination Treatment in Control of Epilepsy.- F. Antitubercular Drugs.- G. Anti-Leprosy Treatments.- H. Peptic Ulcer Therapy.- I. Non-Insulin-Dependent (Maturity Onset) Diabetes.- J. Cancer Chemotherapy.- K. Beneficial Interactions: A Philosophical Approach.- References.- 9 In Vitro Drug Interactions.- A. Introduction.- B. Incompatibility Interactions.- C. In Vitro Drug Interactions with Pharmaceutical Packaging and Intravenous Administration Equipment.- I. General Properties of Plastics.- II. General Properties of Glass.- III. Mechanisms of Interaction with Pharmaceutical Packaging.- 1. Sorption.- 2. Leaching.- 3. Permeation.- 4. Polymer Modification.- IV. Drug Interactions with Contact Lenses.- D. In Vitro Drug Interactions in Therapeutic Drug Monitoring and Drug Analysis.- I. Cyclosporin.- II. Chloroquine.- E. In Vitro Drug Interactions as a Result of Formulation Changes.- I. Problems with Sustained-Release Formulations.- II. Drug Excipient Interactions.- III. Formulation Effects on Rectal Bioavailability.- F. Conclusions.- References.- 10 Age and Genetic Factors in Drug Interactions.- A. Introduction.- B.Age.- I. Pharmacokinetics in the Elderly.- 1. Absorption.- 2. Distribution.- 3. Metabolism.- 4. Excretion.- II. Pharmacodynamics in the Elderly.- III. Inappropriate, Unnecessary and Interacting Medication.- IV. Logistics: Age and Medicine Consumption.- V. Long-Term Treatments.- C. Genetic Factors.- D. Comment.- References.- 11 Drugs Causing Interference with Laboratory Tests.- A. Introduction.- B. Mechanisms of Drug-Test Interactions.- I. Pharmacological Interferences.- 1. Effect on Glucose Determination.- 2. Effect on Uric Acid Determination.- 3. Intramuscular Injections and Muscle Enzyme Determination.- 4. Effect of Drug-Drug Interactions.- II. Methodological Interferences.- 1. Colorimetrie Interferences.- 2. Effect on pH of the Assay Environment.- 3. Interference with Chromatographic Methods.- 4. Interference with Enzymatic Reactions.- 5. Interference with Immunoassays.- C. Design of a Study for Evaluation of Analytical Interference.- D. Conclusions.- References.- 12 Drug Interactions with Herbal and Other Non-orthodox Remedies.- A. Introduction.- B. Animal Agents.- I. Fish Oil.- II. Chinese Toad Venom.- C. Amino Acids.- I. l-Tryptophan.- D. Vitamins.- E. Minerals.- F. Dietary Fads.- G. Herbal Drugs.- I. Effects of Herbal Drugs on Orthodox Drug Pharmacokinetics: Effects on Absorption.- 1. Dietary Fibres.- 2. Guar Gum.- 3. Tannins.- II. Effects of Herbal Drugs on Orthodox Drug Pharmacokinetics: Effects on Elimination.- 1. Cola Nut.- 2. Eucalyptus Species.- 3. Grapefruit Juice.- 4. Herbal Smoking Preparations.- 5. Kampo Medicines.- 6. Liquorice.- III. Effects of Orthodox Drugs on Herbal Drug Pharmacokinetics.- 1. Caffeine-Containing Herbs.- 2. Sparteine-Containing Herb.- 3. Teucrium chamaedrys.- IV. Pharmacodynamic Interactions Between Herbal Drugs and Orthodox Drugs.- 1. Betel Nut (Areca catechu).- 2. Garlic (Allium sativum).- 3. Karela (Momordica charantia).- 4. Liquorice (Glycyrrhiza glabra).- 5. Picrorhiza kurroa.- V. Multiple or Unclarified Interactions Between Herbal Drugs and Orthodox Drugs.- 1. Anthranoid Laxatives.- 2. Berberine.- 3. Ginseng (Pamax ginseng).- 4. Piperine.- 5. "Shankhapusphi".- 6. Yohimbine.- VI. Interactions Between Different Herbal Drugs.- H. Comment.- References.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: September, 2011
Pages: 386
Weight: 581g
Availability: Available
Subcategories: Biochemistry, Diseases and Disorders, Pharmacology
From the same series
Roger G. Pertwee
Philip K. Moore
Kathleen M. Kantak
Alan Cowan
Hans-Georg Schaible
Arnold von Eckardstein
Mark A. Geyer
Botond Berde
Lorenzo A. Pinna
Arnold von Eckardstein
Mark A. Geyer
Anthony R.M. Coates
Vera Regitz-Zagrosek
Ursula F. Habenicht
Christoph Stein
Fabrizio Benedetti
Paolo Gresele
O. Eichler
Clive P. Page
Peter Ruben
G. Peters
Gary R. Lewin
Allison D. Fryer
Hans-Georg Joost
Vsevolod V. Gurevich
Hannsjorg W. Seyberth
Sharron H. Francis
George B. Koelle
Marc Humbert
G Kimmerle
Martha Merrow
Erich Gulbins
Martin C. Michel
Mathias Schwanstecher
Erich Gulbins
Martin F. Fromm
Ross G. Cameron
Hanns Mohler
Mark A. Geyer
F. Clementi
Peter Holzer
Gaetano Di Chiara
Anthony R. M. Coates
David S. Latchman
Siamon Gordon
Bernard Testa
Michael Oettel
B. Mayer
Klaus, von der Helm
Sheldon H. Preskorn
Lutz Hein
Heinz Nau
Stanley T. Crooke
J.M. Monti
Martin C. Michel
Vera Regitz-Zagrosek
Mark A. Geyer
G. Peters
Paolo Gresele
Manfred Gossen
Maynard B. Chenoweth
W. McD. Armstrong
Clive P. Page
Monika Schafer-Korting
Detlef Thieme
Fiona Cunningham
Vittorio Erspamer
Hans H. Ussing
Oskar Eichler
Ervin G. Erdös
S. Bettini
R.E.M. Bowden
John Morley
P.S. Randall
H. Winkler
R Jahn
J. Harenberg
F. Bachmann
D.J. Atherton
M.T. Jones
Frank A. Smith
Timothy D. Warner
Jochen Kuhlmann
James R. Gillette
Joel Bockaert
M. Chatterjee
A.P. Weetman
M. Sovak
Clive P. Page
James William Fisher
Hans-Georg Joost
D.I. Abramson
H.P. Witschi
R. Assan
Alfred J. Clark
J.M. van Rossum
Helmut Greim
Allison D. Fryer
Michael Oettel
M.L. Sears
R. Hess
P.E. Came
C.F. Arlett
H. Mehnert
W.N. Kelley
Luc P. Balant
Alan C. Sartorelli
Gregory R. Mundy
W. R. Martin
Peter Perlman
Michael B. Sporn
Harold C. Hodge
David R. Brown
C. Muller
J. Erik Jorpes
H.E. Voss
Peter Frederick Baker
Pedro Cuatrecasas
Laszlo Szekeres
Fritz Markwardt
R. Baserga
D.A. Kharkevich
H. Vanden Bossche
Stephen H. Caldwell
Ronald T. Borchardt
Alain L. de Weck
Lawrence E. Bryan
T.J. Campbell
F. Lang
K. Bartmann
Donald B. Calne
E.M. Johnson
G.H. Hitchings
Arnold L. Demain
Eugen Dorzbach
U. Peters
M. Green
A. S. Milton
R. Baurain
Brian W. Fox
W. Bleifeld
P. Actor
H. Vanden Bossche
Victor P. Whittaker
Ullrich Trendelenburg
D. Janz
Börje Uvnäs
H.G. Baumgarten
J. A. Nathanson
Frederick C. Kauffman
S. Silver
Kurt Greeff
B. Babudieri
J.G. Banwell
T.T. Aoki
A.L. Jr. Ager
M. Ackenheil
M. Rocha e Silva
Carlo Patrono
Hamao Umezawa
W. Rogalski
G. R. Strichartz
E.C. Foulkes
P. Needleman
E. Anggard
H. Schmidt
C. Braestrup
L.G. Abood
D.A. Kharkevich
C.-Y. Lee
Charles D. Kochakian
Robert Charlier
A.C. Allison
I.H. Page
James R. Gillette
Hermann Blaschko
K.W. Bock
Dean H. Lockwood
A. Dickenson
Franz von Bruchhausen
Robert J. Kavlock
Andrew C.G. Uprichard
P.J. Lefebvre
Mervyn J. Eadie
Franz Hefti
Ross G. Cameron
John G. Csernansky
Michael J. Kuhar
Hannsjorg W. Seyberth
Sharron H. Francis
Mathias Schwanstecher
Martin C. Michel
Martin R. Wilkins
Martin F. Fromm
Peter Redfern
Klaus Aktories
Jurgen Behrens
Harri U. Vainio
Michael Williams
Dennis W. Choi
Gaetano Di Chiara
Peter Jonas
Salvador Moncada
Stefan Bauer
Markus Schwaiger
Markus Schwaiger
Jurgen Schuttler
Hans-Georg Krausslich
Veit M. Flockerzi
Harald H.H.W. Schmidt
Thomas C. Sudhof
Eric Beitz
Kian Fan Chung
Andreas Michael Zeiher
Yuti Chernajovsky
Jack E. Henningfield
Giovanna Lombardi
Salvador Moncada
Florian Holsboer
Enno Klussmann
Clive P. Page
Bertil B. Fredholm
Ursula F. Habenicht
Fiona Cunningham
Monika Schafer-Korting
Matthias Gaestel
Volker A. Erdmann
Robert E. Kass
Harald Sitte
Detlef Thieme
Domenico Spina
Constance N. Wilson
Jack E. Henningfield
Eric Beitz
Harald H.H.W. Schmidt
Giovanna Lombardi
Hans-Georg Krausslich
Kian Fan Chung
Markus Schwaiger
Markus Schwaiger
Enno Klussmann
Anna M. Wobus
Jurgen Schuttler
Thomas C. Sudhof
Stefan Bauer
Yuti Chernajovsky
Andreas Michael Zeiher
Veit M. Flockerzi
Christoph Stein
Salvador Moncada
Salvador Moncada
Harald Sitte